Sol-Gel Technologies (SLGL) Shares Outstanding (2016 - 2026)

Sol-Gel Technologies' (SLGL) quarterly Shares Outstanding (Entity) came in at $2.8 million in Q1 2026, up 1.84% year-on-year from $2.8 million in Q1 2025, and up 1.82% on a QoQ basis from $2.8 million in Q4 2025.

Sol-Gel Technologies (SLGL) Shares Outstanding (2016 - 2026) Analysis & Trends

Sol-Gel Technologies (SLGL) has 11 years of Shares Outstanding (Entity) data on file, last reported at $2.8 million in Q1 2026.

  • On a quarterly basis, Shares Outstanding (Entity) rose 1.84% year-over-year to $2.8 million in Q1 2026; TTM through Mar 2026 was $2.8 million, a 1.84% increase from a year earlier, with the FY2025 full-year figure at $2.8 million, changed 0.01% from the prior year.
  • Shares Outstanding (Entity) for Q1 2026 stood at $2.8 million, up from $2.8 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Entity) for SLGL reached as high as $2.8 million in Q1 2026 and fell as low as $2.3 million in Q1 2022.
  • Historically, Shares Outstanding (Entity) has averaged $2.7 million across 5 years, with a median of $2.8 million in 2023.
  • Across the five-year window, Shares Outstanding (Entity) grew 20.44% in 2023 and changed 0.0% in 2024, its largest moves.
  • Year by year, Shares Outstanding (Entity) stood at $2.3 million in 2022, then advanced by 20.44% to $2.8 million in 2023, then changed by 0.0% to $2.8 million in 2024, then increased by 0.01% to $2.8 million in 2025, then advanced by 1.82% to $2.8 million in 2026.
  • Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $2.8 million in Q1 2026, $2.8 million in Q4 2025, and $2.8 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 6,012.74 Bn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - 47.82 Bn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 118.76 Bn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 1.44 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 254.10 Mn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 104.00 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - 400.00 Mn
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 62.06 Mn
9 Revolution Medicines 37.37 Bn 37.37 Bn - 198.10 Mn
10 Sol-Gel Technologies 234.04 Mn 223.91 Mn - 2.84 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.84 Mn
Dec 31, 2025 2.79 Mn
Sep 30, 2025 2.79 Mn
Jun 30, 2025 2.79 Mn
Mar 31, 2025 2.79 Mn
Dec 31, 2024 2.79 Mn
Sep 30, 2024 2.79 Mn
Jun 30, 2024 2.79 Mn
Mar 31, 2024 2.79 Mn
Dec 31, 2023 2.71 Mn
Sep 30, 2023 2.78 Mn
Jun 30, 2023 2.77 Mn
Mar 31, 2023 2.49 Mn
Dec 31, 2022 2.31 Mn
Sep 30, 2022 2.31 Mn
Jun 30, 2022 2.31 Mn
Mar 31, 2022 2.31 Mn
Dec 31, 2021 2.31 Mn
Sep 30, 2021 2.31 Mn
Jun 30, 2021 2.30 Mn